Monika Janeczko

649 total citations
28 papers, 509 citations indexed

About

Monika Janeczko is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Monika Janeczko has authored 28 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Monika Janeczko's work include Antifungal resistance and susceptibility (10 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Fungal Infections and Studies (5 papers). Monika Janeczko is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Fungal Infections and Studies (5 papers). Monika Janeczko collaborates with scholars based in Poland, France and Spain. Monika Janeczko's co-authors include Maciej Masłyk, Konrad Kubiński, Hieronim Golczyk, Oleg M. Demchuk, Ángel Amesty, Ana Estévez‐Braun, Ryszard Szyszka, Tomasz Skrzypek, Andrea Baier and Sunirmal Sheet and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Monika Janeczko

25 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Janeczko Poland 12 212 190 119 74 55 28 509
Konrad Kubiński Poland 15 302 1.4× 329 1.7× 85 0.7× 53 0.7× 49 0.9× 45 748
Felipe Augusto Rocha Rodrigues Brazil 16 269 1.3× 194 1.0× 71 0.6× 52 0.7× 74 1.3× 37 693
Muhammed Tılahun Muhammed Türkiye 13 296 1.4× 326 1.7× 40 0.3× 40 0.5× 67 1.2× 67 788
Vibha Yadav India 13 319 1.5× 145 0.8× 34 0.3× 43 0.6× 48 0.9× 36 625
Márta Nové Hungary 13 115 0.5× 138 0.7× 74 0.6× 24 0.3× 61 1.1× 25 362
G. L. Sharma India 13 289 1.4× 151 0.8× 36 0.3× 44 0.6× 88 1.6× 24 614
Kamal Ahmad India 14 270 1.3× 228 1.2× 26 0.2× 71 1.0× 47 0.9× 40 591
Gao-Xiong Rao China 15 190 0.9× 225 1.2× 35 0.3× 32 0.4× 50 0.9× 48 586
Gaopeng Song China 17 245 1.2× 424 2.2× 57 0.5× 56 0.8× 31 0.6× 57 804
Nikoletta Szemerédi Hungary 13 121 0.6× 168 0.9× 48 0.4× 19 0.3× 58 1.1× 49 426

Countries citing papers authored by Monika Janeczko

Since Specialization
Citations

This map shows the geographic impact of Monika Janeczko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Janeczko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Janeczko more than expected).

Fields of papers citing papers by Monika Janeczko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Janeczko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Janeczko. The network helps show where Monika Janeczko may publish in the future.

Co-authorship network of co-authors of Monika Janeczko

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Janeczko. A scholar is included among the top collaborators of Monika Janeczko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Janeczko. Monika Janeczko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janeczko, Monika & Tomasz Skrzypek. (2025). Relationships Between Candida auris and the Rest of the Candida World—Analysis of Dual-Species Biofilms and Infections. Pathogens. 14(1). 40–40. 2 indexed citations
2.
Janeczko, Monika, et al.. (2024). Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients. Microbiology Spectrum. 12(3). e0365223–e0365223. 3 indexed citations
3.
Kubiński, Konrad, Monika Janeczko, Maciej Masłyk, et al.. (2023). Silver Is Not Equal to Silver: Synthesis and Evaluation of Silver Nanoparticles with Low Biological Activity, and Their Incorporation into C12Alanine-Based Hydrogel. Molecules. 28(3). 1194–1194. 8 indexed citations
4.
Golczyk, Hieronim, Eva Hřibová, Jaroslav Doležel, et al.. (2022). Migration of repetitive DNAs during evolution of the permanent translocation heterozygosity in the oyster plant (Tradescantia section Rhoeo). Chromosoma. 131(3). 163–173. 1 indexed citations
6.
Łapiński, Andrzej, Oleg M. Demchuk, Konrad Kubiński, et al.. (2021). New Supramolecular Drug Carriers: The Study of Organogel Conjugated Gold Nanoparticles. Molecules. 26(24). 7462–7462. 5 indexed citations
7.
Biernasiuk, Anna, Maciej Masłyk, Monika Janeczko, et al.. (2021). Synthesis and Physicochemical Characterization of Novel Dicyclopropyl-Thiazole Compounds as Nontoxic and Promising Antifungals. Materials. 14(13). 3500–3500. 3 indexed citations
8.
Jach, Monika Elżbieta, Ewa Sajnaga, Monika Janeczko, et al.. (2021). Production of enriched in B vitamins biomass of Yarrowia lipolytica grown in biofuel waste. Saudi Journal of Biological Sciences. 28(5). 2925–2932. 10 indexed citations
10.
Pitucha, Monika, Monika Janeczko, Katarzyna Klimek, et al.. (2020). 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors. Bioorganic Chemistry. 99. 103806–103806. 23 indexed citations
11.
Masłyk, Maciej, Monika Janeczko, Małgorzata Tokarska-Rodak, et al.. (2019). The Anti-Candida albicans Agent 4-AN Inhibits Multiple Protein Kinases. Molecules. 24(1). 153–153. 6 indexed citations
12.
Janeczko, Monika. (2018). Emodin Reduces the Activity of (1,3)- β -D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin. Polish Journal of Microbiology. 67(4). 463–470. 21 indexed citations
13.
Janeczko, Monika, et al.. (2018). Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives. Molecules. 23(1). 199–199. 84 indexed citations
14.
Masłyk, Maciej, et al.. (2017). CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity. Molecular and Cellular Biochemistry. 435(1-2). 193–196. 14 indexed citations
15.
Janeczko, Monika, Maciej Masłyk, Konrad Kubiński, & Hieronim Golczyk. (2017). Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans. Yeast. 34(6). 253–265. 65 indexed citations
16.
Masłyk, Maciej, Monika Janeczko, Oleg M. Demchuk, et al.. (2017). A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro. Saudi Pharmaceutical Journal. 26(2). 244–252. 6 indexed citations
17.
Janeczko, Monika, et al.. (2016). New family of antimicrobial agents derived from 1,4-naphthoquinone. European Journal of Medicinal Chemistry. 124. 1019–1025. 64 indexed citations
18.
Janeczko, Monika, Zygmunt Kazimierczuk, Andrzej Orzeszko, et al.. (2016). In Search of the Antimicrobial Potential of Benzimidazole Derivatives. Polish Journal of Microbiology. 65(3). 359–364. 8 indexed citations
19.
Janeczko, Monika, Andrzej Orzeszko, Zygmunt Kazimierczuk, Ryszard Szyszka, & Andrea Baier. (2011). CK2α and CK2α′ subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. European Journal of Medicinal Chemistry. 47(1). 345–350. 27 indexed citations
20.
Janeczko, Monika, Maciej Masłyk, Ryszard Szyszka, & Andrea Baier. (2011). Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors. Molecular and Cellular Biochemistry. 356(1-2). 121–126. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026